Clinical Implications of the Presence of HALT in TAVR Patients: 5-Year Follow-Up

The duration of percutaneous aortic valve implants can be increasingly observed over time, regardless of their corresponding surgical risk. In the follow-up of different registries, the presence of subclinical valvular thrombosis, evidenced in tomographic studies as an increase in valvular thickness with hypoattenuation (a term known as HALT), was observed from protocolized images. 

Anillos aórticos pequeños, ¿Qué válvula deberíamos elegir?

This subclinical thrombosis was observed more frequently in transcatheter aortic valve replacement (TAVR) patients compared with patients undergoing surgical replacement. However, little is known about how its presence impacts clinical outcomes.

The Japanese group Imaeda et al. conducted a retrospective analysis of its own database to investigate the natural history of HALT and its relationship with long-term outcomes.

All patients underwent SAPIEN-XT valve implantation and follow-up with echocardiography and multidetector computed tomography (MDCT) at discharge, at 6 months, and at an annual follow-up for 5 years.

Data were obtained from 124 patients, who received dual antiplatelet therapy (DAPT) for 6 months, divided into two groups: HALT and non-HALT. The primary endpoint (PEP) was a composite of all-cause mortality, hospitalization for heart failure (HF), and ischemic stroke. Secondary endpoints were the incidence of all-cause mortality, cardiovascular death, HF hospitalization, and ischemic stroke. In turn, valvular performance was assessed using indexed effective orifice area, mean pressure gradient, and indexed stroke volume as variables.

Read also: We Should Treat Significant Stable CAD in Patients Undergoing TAVR.

The incidence of HALT at one year was 21.8%; there were no significant differences in baseline characteristics, except for a greater presence of CF III dyspnea or higher in the non-HALT group (p = 0.04). In the mean follow-up of 4.7 years, there were no significant differences in the PEP, with an incidence of 37% in the HALT group vs. 38.1% in the non-HALT group (log-rank test, = 0.92). There were no significant differences in secondary endpoints such as all-cause mortality (p = 0.97), cardiovascular death (p = 0.86), hospitalization for HF (p = 0.54), and ischemic stroke (p = 0.88).

The presence of HALT was not associated with decreased effective orifice area (p = 0.59), increased gradient (p = 0.76), or decreased stroke indexed volume (p = 0.29).

CONCLUSIONS

In this study, the incidence of HALT was 21.8%, and its presence did not imply changes in the clinical endpoints and in valvular performance at the 5-year follow-up of these patients. This dedicated study allows us to develop hypotheses regarding the innocent nature of this entity. However, due to the small sample size, derived from a single center, reliable conclusions cannot be drawn.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the editorial board of SOLACI.org.

Original Title: Natural History of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A 5-Year Follow-Up Study.

Reference: Imaeda, Shohei et al. “Natural History of Leaflet Thrombosis After Transcatheter Aortic Valve Replacement: A 5-Year Follow-Up Study.” Journal of the American Heart Association vol. 11,23 (2022): e026334. doi:10.1161/JAHA.122.026334.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Multicenter Experience with 3D Intracardiac Echocardiography for Guiding Interventional Cardiac Procedures

Courtesy of Dr. Juan Manuel Pérez. Imaging techniques play a fundamental role in interventional cardiac procedures. Intracardiac echocardiography (ICE) appears as an alternative to transesophageal...

Pathology of Self-Expanding Transcatheter Aortic Bioprostheses and Hypoattenuated Leaflet Thickening

Courtesy of Dr. Juan Manuel Pérez. Despite the available long term followup data on of transcatheter aortic valve replacement (TAVR), bioprosthesis durability continues under debate....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...